Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

High BIN1 expression has a favorable prognosis in malignant pleural mesothelioma and is associated with tumor infiltrating lymphocytes.

Ahmadzada T, Lee K, Clarke C, Cooper WA, Linton A, McCaughan B, Asher R, Clarke S, Reid G, Kao S.

Lung Cancer. 2019 Apr;130:35-41. doi: 10.1016/j.lungcan.2019.02.005. Epub 2019 Feb 7.

PMID:
30885349
2.

An Update on Predictive Biomarkers for Treatment Selection in Non-Small Cell Lung Cancer.

Ahmadzada T, Kao S, Reid G, Boyer M, Mahar A, Cooper WA.

J Clin Med. 2018 Jun 15;7(6). pii: E153. doi: 10.3390/jcm7060153. Review.

3.

Biomarkers in malignant pleural mesothelioma: current status and future directions.

Ahmadzada T, Reid G, Kao S.

J Thorac Dis. 2018 Apr;10(Suppl 9):S1003-S1007. doi: 10.21037/jtd.2018.04.31. No abstract available.

4.

Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer.

Ahmadzada T, Reid G, McKenzie DR.

Biophys Rev. 2018 Feb;10(1):69-86. doi: 10.1007/s12551-017-0392-1. Epub 2018 Jan 11. Review.

Supplemental Content

Loading ...
Support Center